<scp>Editorial Comment</scp>
摘要
In this issue of Epilepsia, we present the next in our series of review, opinion, and commentary (pp. 1277–1288). Other such series, published in Gray Matters over the past couple of years, include discussions about: ethical dimensions of epilepsy genetics [2006, 47(10):1747–1756]; internet research [2007, 48(7):1415–1424]; drug resistance [2007, 48(12):2369–2374]; SCN1A mutation and sudden unexplained death in epilepsy (SUDEP) [2008, 49(2)360–369]; and Wada testing [2008-49(4):715–727]. One reader has pointed out that we have not explained the format or purpose of these series, and so we have now added a section heading to clarify our intent. In these series, we publish a lead paper followed by commentaries that have been invited by the editors specifically to put forward different views. In commissioning such commentary, we hope to encourage discussion and debate that will lead to further research and elucidation of these still controversial issues. We hope this initiative is of interest to readers, and we invite readers to suggest new topic areas for debate within the pages of Epilepsia.